O75533 (SF3B1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Splicing factor 3B subunit 1 Alternative name(s): Pre-mRNA-splicing factor SF3b 155 kDa subunit Short name=SF3b155 Spliceosome-associated protein 155 Short name=SAP 155 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1304 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Subunit of the splicing factor SF3B required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA. May also be involved in the assembly of the 'E' complex. Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron. |
| Subunit structure | Identified in the spliceosome C complex. Component of the U11/U12 snRNPs that are part of the U12-type spliceosome. Component of splicing factor SF3B which is composed of at least eight subunits; SF3B1/SAP155/SF3B155, SF3B2/SAP145/SF3B155, SF3B3/SAP130/SF3B130, SF3B4/SAP49/SF3B49, SF3B14A, PHF5A/SF3B14B, SF3B10 and SF3B125.Component of the B-WICH complex, at least composed of SMARCA5/SNF2H, BAZ1B/WSTF, SF3B1, DEK, MYO1C, ERCC6, MYBBP1A and DDX21. SF3B associates with the splicing factor SF3A and a 12S RNA unit to form the U2 small nuclear ribonucleoproteins complex (U2 snRNP). SF3B1 interacts directly with the splicing factor U2AF. Phosphorylated form interacts with PPP1R8. Ref.6 |
| Subcellular location | Nucleus speckle. Note: During mitosis, transiently dispersed from the nuclear speckles to the cytoplasm. |
| Post-translational modification | Phosphorylated. Phosphorylation occurs concomitantly with the splicing catalytic steps. Phosphorylation on Thr-244, Thr-248 and Thr-313 by cyclin-dependent kinases promotes interaction with PPP1R8 during mitosis. Ref.1 Ref.6 Ref.9 Ref.11 Ref.12 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 Ref.20 |
| Sequence similarities | Belongs to the SF3B1 family. Contains 11 HEAT repeats. |
Ontologies
| Keywords | |
|---|---|
| Biological process | mRNA processing mRNA splicing |
| Cellular component | Nucleus Spliceosome |
| Domain | Repeat |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | nuclear mRNA splicing, via spliceosome Non-traceable author statement Ref.1. Source: UniProtKB |
| Cellular component | U12-type spliceosomal complex Inferred from direct assay Ref.10. Source: UniProtKB catalytic step 2 spliceosomeInferred from direct assay Ref.7. Source: UniProtKB nuclear speckInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||
Molecule processing | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1304 | 1304 | Splicing factor 3B subunit 1 | PRO_0000174323 | |||||||||||
Regions | |||||||||||||||
| Repeat | 529 – 568 | 40 | HEAT 1 | ||||||||||||
| Repeat | 569 – 603 | 35 | HEAT 2 | ||||||||||||
| Repeat | 604 – 641 | 38 | HEAT 3 | ||||||||||||
| Repeat | 643 – 677 | 35 | HEAT 4 | ||||||||||||
| Repeat | 680 – 718 | 39 | HEAT 5 | ||||||||||||
| Repeat | 763 – 801 | 39 | HEAT 6 | ||||||||||||
| Repeat | 843 – 881 | 39 | HEAT 7 | ||||||||||||
| Repeat | 1010 – 1048 | 39 | HEAT 8 | ||||||||||||
| Repeat | 1052 – 1090 | 39 | HEAT 9 | ||||||||||||
| Repeat | 1122 – 1160 | 39 | HEAT 10 | ||||||||||||
| Repeat | 1163 – 1201 | 39 | HEAT 11 | ||||||||||||
| Region | 223 – 491 | 269 | Interaction with PPP1R8 | ||||||||||||
| Region | 529 – 568 | 40 | Interaction with SF3B14 | ||||||||||||
Amino acid modifications | |||||||||||||||
| Modified residue | 129 | 1 | Phosphoserine Ref.18 Ref.20 | ||||||||||||
| Modified residue | 141 | 1 | N6-acetyllysine Ref.21 | ||||||||||||
| Modified residue | 142 | 1 | Phosphothreonine Ref.15 Ref.18 | ||||||||||||
| Modified residue | 194 | 1 | Phosphoserine Ref.18 Ref.19 | ||||||||||||
| Modified residue | 207 | 1 | Phosphothreonine Ref.14 Ref.18 Ref.19 Ref.20 | ||||||||||||
| Modified residue | 211 | 1 | Phosphothreonine Ref.12 Ref.14 Ref.17 Ref.18 Ref.19 Ref.20 | ||||||||||||
| Modified residue | 223 | 1 | Phosphothreonine Ref.12 Ref.15 Ref.16 Ref.18 Ref.20 | ||||||||||||
| Modified residue | 227 | 1 | Phosphothreonine Ref.16 Ref.18 Ref.20 | ||||||||||||
| Modified residue | 235 | 1 | Phosphothreonine Ref.11 Ref.18 | ||||||||||||
| Modified residue | 244 | 1 | Phosphothreonine Ref.6 Ref.15 | ||||||||||||
| Modified residue | 248 | 1 | Phosphothreonine Probable | ||||||||||||
| Modified residue | 257 | 1 | Phosphothreonine Ref.16 | ||||||||||||
| Modified residue | 261 | 1 | Phosphothreonine Ref.16 | ||||||||||||
| Modified residue | 267 | 1 | Phosphothreonine Ref.16 Ref.19 | ||||||||||||
| Modified residue | 273 | 1 | Phosphothreonine Ref.19 | ||||||||||||
| Modified residue | 278 | 1 | Phosphothreonine By similarity | ||||||||||||
| Modified residue | 296 | 1 | Phosphothreonine Ref.12 | ||||||||||||
| Modified residue | 299 | 1 | Phosphothreonine Ref.12 Ref.16 | ||||||||||||
| Modified residue | 313 | 1 | Phosphothreonine Probable | ||||||||||||
| Modified residue | 316 | 1 | Phosphothreonine Ref.12 | ||||||||||||
| Modified residue | 322 | 1 | Phosphoserine Ref.19 | ||||||||||||
| Modified residue | 326 | 1 | Phosphothreonine Ref.12 Ref.14 Ref.18 Ref.19 Ref.20 | ||||||||||||
| Modified residue | 328 | 1 | Phosphothreonine Ref.14 Ref.18 Ref.19 | ||||||||||||
| Modified residue | 332 | 1 | Phosphoserine Ref.18 Ref.20 | ||||||||||||
| Modified residue | 341 | 1 | Phosphothreonine Ref.20 | ||||||||||||
| Modified residue | 344 | 1 | Phosphoserine Ref.9 | ||||||||||||
| Modified residue | 349 | 1 | Phosphoserine Ref.19 Ref.20 | ||||||||||||
| Modified residue | 350 | 1 | Phosphothreonine Ref.9 Ref.19 Ref.20 | ||||||||||||
| Modified residue | 354 | 1 | Phosphothreonine Ref.9 Ref.17 Ref.19 | ||||||||||||
| Modified residue | 400 | 1 | Phosphoserine Ref.20 | ||||||||||||
| Modified residue | 432 | 1 | Phosphothreonine Ref.16 | ||||||||||||
| Modified residue | 434 | 1 | Phosphothreonine Ref.20 | ||||||||||||
| Modified residue | 436 | 1 | Phosphothreonine Ref.20 | ||||||||||||
| Modified residue | 488 | 1 | Phosphoserine Ref.17 Ref.18 Ref.19 | ||||||||||||
| Modified residue | 554 | 1 | N6-acetyllysine Ref.21 | ||||||||||||
| Modified residue | 562 | 1 | N6-acetyllysine Ref.21 | ||||||||||||
Experimental info | |||||||||||||||
| Mutagenesis | 223 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 227 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 235 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 244 | 1 | T → A: Slight inhibition of interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 248 | 1 | T → A: Slight inhibition of interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 257 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 261 | 1 | T → A: Slight inhibition of interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 267 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 273 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 278 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 296 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 303 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Mutagenesis | 313 | 1 | T → A: No effect on interaction with PPP1R8. Ref.6 | ||||||||||||
| Sequence conflict | 149 | 1 | A → V in AAC97189. Ref.1 | ||||||||||||
| Sequence conflict | 594 | 1 | R → L in AAC97189. Ref.1 | ||||||||||||
Secondary structure | |||||||||||||||
Helix Strand Turn | |||||||||||||||
| Helix | 380 – 395 | 16 | |||||||||||||
| Helix | 401 – 405 | 5 | |||||||||||||
| Beta strand | 410 – 414 | 5 | |||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis." Wang C., Chua K., Seghezzi W., Lees E., Gozani O., Reed R. Genes Dev. 12:1409-1414(1998) [PubMed: 9585501] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION. |
| [2] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Yu W., Gibbs R.A. Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1011-1304. Tissue: Brain. |
| [4] | "Functional association of U2 snRNP with the ATP-independent spliceosomal complex E." Das R., Zhou Z., Reed R. Mol. Cell 5:779-787(2000) [PubMed: 10882114] [Abstract] Cited for: CHARACTERIZATION OF THE SPLICEOSOME. |
| [5] | "Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein." Will C.L., Urlaub H., Achsel T., Gentzel M., Wilm M., Luehrmann R. EMBO J. 21:4978-4988(2002) [PubMed: 12234937] [Abstract] Cited for: IDENTIFICATION IN THE SF3B COMPLEX. |
| [6] | "Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1." Boudrez A., Beullens M., Waelkens E., Stalmans W., Bollen M. J. Biol. Chem. 277:31834-31841(2002) [PubMed: 12105215] [Abstract] Cited for: INTERACTION WITH PPP1R8, PHOSPHORYLATION AT THR-244; THR-248 AND THR-313, MUTAGENESIS OF THR-223; THR-227; THR-235; THR-244; THR-248; THR-257; THR-261; THR-267; THR-273; THR-278; THR-296; THR-303 AND THR-313. |
| [7] | "Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis." Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J. RNA 8:426-439(2002) [PubMed: 11991638] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE SPLICEOSOMAL C COMPLEX. |
| [8] | "Molecular architecture of the multiprotein splicing factor SF3b." Golas M.M., Sander B., Will C.L., Luhrmann R., Stark H. Science 300:980-984(2003) [PubMed: 12738865] [Abstract] Cited for: IDENTIFICATION IN THE SF3B COMPLEX, ELECTRON MICROSCOPY OF THE SF3B COMPLEX. |
| [9] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344; THR-350 AND THR-354, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome." Will C.L., Schneider C., Hossbach M., Urlaub H., Rauhut R., Elbashir S., Tuschl T., Luehrmann R. RNA 10:929-941(2004) [PubMed: 15146077] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH THE U11/U12 SPLICEOSOME, MASS SPECTROMETRY. |
| [11] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-235, MASS SPECTROMETRY. Tissue: Colon adenocarcinoma. |
| [12] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211; THR-223; THR-296; THR-299; THR-316 AND THR-326, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription." Cavellan E., Asp P., Percipalle P., Oestlund Farrants A.-K. J. Biol. Chem. 281:16264-16271(2006) [PubMed: 16603771] [Abstract] Cited for: IDENTIFICATION IN THE B-WICH COMPLEX. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-207; THR-211; THR-326 AND THR-328, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-142; THR-223 AND THR-244, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-223; THR-227; THR-257; THR-261; THR-267; THR-299 AND THR-432, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211; THR-354 AND SER-488, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-142; SER-194; THR-207; THR-211; THR-223; THR-227; THR-235; THR-326; THR-328; SER-332 AND SER-488, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194; THR-207; THR-211; THR-267; THR-273; SER-322; THR-326; THR-328; SER-349; THR-350; THR-354 AND SER-488, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [20] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; THR-207; THR-211; THR-223; THR-227; THR-326; SER-332; THR-341; SER-349; THR-350; SER-400; THR-434 AND THR-436, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [21] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-141; LYS-554 AND LYS-562, MASS SPECTROMETRY. |
| [22] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [23] | "NMR solution structure of the human spliceosomal protein complex p14-SF3B155." RIKEN structural genomics initiative (RSGI) Submitted (JAN-2007) to the PDB data bank Cited for: STRUCTURE BY NMR OF 379-424. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF054284 mRNA. Translation: AAC97189.1. AC010746 Genomic DNA. No translation available. AF070540 mRNA. Translation: AAC28633.1. | ||||||||||||||||||||||||||||||||||||
| IPI | IPI00026089. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_036565.2. NM_012433.2. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.632554. | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | O75533. | ||||||||||||||||||||||||||||||||||||
| SMR | O75533. Positions 379-424, 1015-1085, 1129-1156, 1215-1243. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| DIP | DIP-29411N. | ||||||||||||||||||||||||||||||||||||
| IntAct | O75533. 15 interactions. | ||||||||||||||||||||||||||||||||||||
| MINT | MINT-1185911. | ||||||||||||||||||||||||||||||||||||
| STRING | O75533. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| PhosphoSite | O75533. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PRIDE | O75533. | ||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000335508; ENSP00000335321; ENSG00000115524. | ||||||||||||||||||||||||||||||||||||
| GeneID | 23451. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:23451. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| CTD | 23451. | ||||||||||||||||||||||||||||||||||||
| GeneCards | GC02M198256. | ||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0200284. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:10768. SF3B1. | ||||||||||||||||||||||||||||||||||||
| MIM | 605590. gene. | ||||||||||||||||||||||||||||||||||||
| neXtProt | NX_O75533. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| HOGENOM | HBG330902. | ||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG079173. | ||||||||||||||||||||||||||||||||||||
| InParanoid | O75533. | ||||||||||||||||||||||||||||||||||||
| OMA | KEWMRIC. | ||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4RJG0Q. | ||||||||||||||||||||||||||||||||||||
| PhylomeDB | O75533. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Reactome | REACT_1675. mRNA Processing. REACT_71. Gene Expression. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | O75533. | ||||||||||||||||||||||||||||||||||||
| Bgee | O75533. | ||||||||||||||||||||||||||||||||||||
| CleanEx | HS_SF3B1. | ||||||||||||||||||||||||||||||||||||
| Genevestigator | O75533. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000115524. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR011989. ARM-like. IPR016024. ARM-type_fold. IPR015016. SF3b_su1. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Gene3D | G3DSA:1.25.10.10. ARM-like. 2 hits. | ||||||||||||||||||||||||||||||||||||
| KO | K12828. | ||||||||||||||||||||||||||||||||||||
| Pfam | PF08920. SF3b1. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF48371. ARM-type_fold. 1 hit. | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS50077. HEAT_REPEAT. False negative. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | O75533. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | SF3B1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O75533 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with